Heterogeneity in Methods of Estimating Kidney Function for Cancer Clinical Trial Eligibility

JAMA Netw Open. 2024 Sep 3;7(9):e2433387. doi: 10.1001/jamanetworkopen.2024.33387.

¹ Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York.
² Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, New York.
³ Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
⁴ Icahn School of Medicine at Mount Sinai, New York, New York.
⁵ Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
⁶ Department of Population Health and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
⁷ Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

Plain language summary

This cross-sectional study examined the kidney-function eligibility criteria for patients for enrollment in contemporary cancer clinical trials.